Osteopontin-c isoform inhibition modulates ovarian cancer cell cisplatin resistance, viability and plasticity

por Brum, Mariana Concentino Menezes, Dos Santos Guimaraes, Isabella, Ferreira, Luciana Bueno, Rangel, Leticia Batista Azevedo, Maia, Raquel Ciuvalschi, De Moraes, Gabriela Nestal, Gimba, Etel R.P.
Publicado 2021

Inhibition of CXCR2 plays a pivotal role in re-sensitizing ovarian cancer to cisplatin treatment

por Henriques, Taciane Barbosa, dos Santos, Diandra Zipinotti, dos Santos Guimarães, Isabella, Tessarollo, Nayara Gusmão, Lyra-Junior, Paulo Cilas Morais, Mesquita, Patricia, Pádua, Diana, Amaral, Ana Luisa, Cavadas, Bruno, Pereira, Luisa, Silva, Ian Victor, Almeida, Raquel Maria da Silva Graça, Rangel, Leticia Batista Azevedo
Publicado 2021